Invention Grant
- Patent Title: Organic compounds
- Patent Title (中): 有机化合物
-
Application No.: US12088608Application Date: 2006-09-28
-
Publication No.: US07795257B2Publication Date: 2010-09-14
- Inventor: Gregory Raymond Bebernitz
- Applicant: Gregory Raymond Bebernitz
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Theresa Devlin
- International Application: PCT/US2006/038200 WO 20060928
- International Announcement: WO2007/041365 WO 20070412
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/496 ; A61K31/4365 ; A61K31/429 ; C07D413/14 ; C07D241/04 ; C07D401/14 ; C07D401/02 ; C07D513/02
Abstract:
The present invention provides compounds of the formula which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, type 2 diabetes and obesity.
Public/Granted literature
- US20080318948A1 Organic Compounds Public/Granted day:2008-12-25
Information query
IPC分类:
